TBRG4 and osteosarcoma: Functional studies demonstrate that TBRG4 knockdown inhibits osteosarcoma cell proliferation, clonogenic ability, and invasion, while inducing apoptosis in vitro; in vivo, it suppresses tumor growth and metastasis (69).